Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ritzel

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes, Obesity & Metabolism|September 2, 2017
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetesRobert Ritzel, Ronan Roussel, Andrea Giaccari, et al.
Diabetes, Obesity & Metabolism|December 12, 2023
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trialsMedha Munshi, Robert Ritzel, Edward B Jude, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T StudyRobert Ritzel, Melanie J Davies, Lichen Hao, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Pulsatile insulin secretion by human pancreatic isletsSoon H Song, Lise Kjems, Robert Ritzel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteersMichael A Nauck, Markus M Heimesaat, Kai Behle, et al.
Diabetes, Obesity & Metabolism|October 25, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT studyAlice Cheng, Stewart Harris, Francesco Giorgino, et al.
Herz|September 2, 2004
[AGE-RAGE: a hypothesis or a mechanism?]Berend Isermann, Angelika Bierhaus, Per M Humpert, et al.
Diabetes, Obesity & Metabolism|June 14, 2023
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naïve people with type 2 diabetes mellitus uncontrolled on oral anti-diabeticsRobert Ritzel, Sujoy Ghosh, Rifat Emral, et al.
Diabetes Research and Clinical Practice|September 29, 2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapyAlice Y Y Cheng, Didac Mauricio, Robert Ritzel, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|September 2, 2017
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetesRobert Ritzel, Ronan Roussel, Andrea Giaccari, et al.
Diabetes, Obesity & Metabolism|December 12, 2023
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trialsMedha Munshi, Robert Ritzel, Edward B Jude, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T StudyRobert Ritzel, Melanie J Davies, Lichen Hao, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Pulsatile insulin secretion by human pancreatic isletsSoon H Song, Lise Kjems, Robert Ritzel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteersMichael A Nauck, Markus M Heimesaat, Kai Behle, et al.
Diabetes, Obesity & Metabolism|October 25, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT studyAlice Cheng, Stewart Harris, Francesco Giorgino, et al.
Herz|September 2, 2004
[AGE-RAGE: a hypothesis or a mechanism?]Berend Isermann, Angelika Bierhaus, Per M Humpert, et al.
Diabetes, Obesity & Metabolism|June 14, 2023
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naïve people with type 2 diabetes mellitus uncontrolled on oral anti-diabeticsRobert Ritzel, Sujoy Ghosh, Rifat Emral, et al.
Diabetes Research and Clinical Practice|September 29, 2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapyAlice Y Y Cheng, Didac Mauricio, Robert Ritzel, et al.
Pageof 2